Mental health issues affect one in four people and the cost of treatment is predicted to reach around US$6 trillion globally by 2030. To enhance access to people who need help in this area, IHH has invested into Intellect, Asia’s leading end-to-end digital mental health company. As Intellect’s first strategic healthcare investor, IHH will be co-developing digital mental health programmes to better care for and support our patients, corporate clients and employees.
IHH’s growing number of innovation investments is in line with its aspiration to Care. For Good. By expanding our capabilities beyond acute care to holistic care and wellness, IHH aims to extend its continuum of services and build a thriving healthcare ecosystem that provides seamless, convenient care through various cutting-edge healthcare technology solutions, medtech services and telehealth platforms.
“Our aspiration to Care. For Good. at IHH has led us to this partnership with Intellect to provide mental health offerings to our patients, corporate clients, and employees, towards building a healthier world,” said Ashok Pandit, Group Chief Strategy & Business Development Officer of IHH Healthcare. “Mental and physical health are equally important components of total well-being. We are pleased to invest in Intellect, a market leader in this rapidly growing category, to boost their growth and enhance access to millions more people who require support, care or treatment.”
In a pilot initiative, maternity patients from Gleneagles Hospital Singapore will be among the first from the IHH network to enjoy Intellect’s offerings. There are also plans to extend Intellect’s solution to corporate clients of IHH Singapore’s iXchange and to IHH employees.
Intellect’s end-to-end mental health services include telehealth coaching, clinical therapy, psychiatry, self-guided cognitive behavioural therapy-based programmes, urgent distress support, and mental health screening – all done either virtually via the Intellect platform or in-person at an Intellect clinic.
Related Stories
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
Mount Elizabeth Hospitals Celebrate 97 Wins at Singapore Health Quality Service Awards 2026
Gleneagles Hospital Johor Opens International Lounge to Enhance Cross-border Care
Fortis Memorial Research Institute Gives Heart Patient a New Lease of Life
Gleneagles Hospital, Mumbai Successfully Treats India’s Youngest POEM Patient
Our team helped an underweight 14-month-old child with a rare swallowing disorder restore the ability to eat and gain weight normally through the minimally invasive procedure.
